PGIM Jennison Health Sciences Fund recently released its third quarter 2024 investor letter. A copy of the letter can be ...
Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, autoimmune, and infectious ...
Organically Human on MSN4h
Two Billion People Have a Brain Parasite – Here's Why Many Haven't NoticedMore than two billion people around the world are infected with a brain parasite called Toxoplasma gondii. This parasite is ...
Cells in the immune system don't always fight; they often rest and wait for threats, like viruses or bacteria.
Cells in the immune system don't always fight; they often rest and wait for threats, like viruses or bacteria. When such ...
Cyrus Biotechnology announces potent in vivo redosability of an engineered IdeS protease for IgG-driven autoimmune disease.
Autoimmune diseases arise when the immune system mistakenly targets and damages the body’s cells and tissues as though they were foreign invaders. This widespread category of illnesses, such as ...
By far, the largest acquisition of 2024 was Novo Holdings' yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion.
In an interview with Ophthalmology Times, Alon Kahana, MD, PhD, discusses interleukin-6 and its role in autoimmune diseases, particularly thyroid eye disease, noting that a promising alternative under ...
Type 1 Diabetes is a lifelong autoimmune condition that prevents a person’s pancreas from producing insulin, the hormone ...
Among the 10 honorees were two researchers from China: Li Chunlai, who played a crucial role in China’s Chang’e-6 lunar ...
In a new study published in Nature, scientists from Gladstone Institutes and UC San Francisco (UCSF) focused on T cells and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback